Home › Interstitial Lung Diseases › Alabama › Birmingham
Interstitial Lung Diseases clinical trials in Birmingham, AL
10 studies for Interstitial Lung Diseases are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingPhase 2
- University of Alabama, Birmingham
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
RecruitingPhase 3
- University of Alabama at Birmingham, Birmingham
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
RecruitingPhase 3
- University of Alabama at Birmingham, Birmingham
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
- UAB Lung Health Center, Birmingham
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Recruiting
- University of Alabama at Birmingham, Birmingham
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingObservational study
- University of Alabama at Birmingham, Birmingham
Platform Clinical Study for Conquering Scleroderma
RecruitingPhase 2
- University of Alabama - Division of Pulmonary and Critical Care Medicine, Birmingham
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
RecruitingObservational study
- University of Alabama - Birmingham, Birmingham
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RecruitingPhase 3
- UAB Lung Health Center, Birmingham
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
- University of Alabama at Birmingham, Birmingham
About Interstitial Lung Diseases
Interstitial lung diseases are a group of diseases that inflame or scar the lungs. Breathing in particles (asbestosis, silicosis) causes some types.
More about Interstitial Lung Diseases on MedlinePlus
Interstitial Lung Diseases trials in other cities
- New York City, NY19 studies
- Philadelphia, PA17 studies
- Los Angeles, CA15 studies
- Kansas City, KS14 studies
- Houston, TX13 studies
- Durham, NC13 studies
- Charleston, SC13 studies
- Chicago, IL13 studies
- Ann Arbor, MI11 studies
- Aurora, CO11 studies
- Boston, MA10 studies
- Rochester, MN10 studies
Other studies in Birmingham
- Cancer (all types)31 studies
- Breast Cancer24 studies
- Obesity23 studies
- Ovarian Cancer23 studies
- Non-Small Cell Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Multiple Myeloma18 studies
- Cardiovascular Disease17 studies
- COPD17 studies
- Overweight16 studies
- Cystic Fibrosis16 studies
- Endometrial Cancer16 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.